Logo image of MYRG

MYR GROUP INC/DELAWARE (MYRG) Stock Fundamental Analysis

NASDAQ:MYRG - Nasdaq - US55405W1045 - Common Stock - Currency: USD

141.09  -0.35 (-0.25%)

After market: 141.09 0 (0%)

Fundamental Rating

4

Taking everything into account, MYRG scores 4 out of 10 in our fundamental rating. MYRG was compared to 47 industry peers in the Construction & Engineering industry. MYRG has only an average score on both its financial health and profitability. MYRG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MYRG had positive earnings in the past year.
In the past year MYRG had a positive cash flow from operations.
In the past 5 years MYRG has always been profitable.
In the past 5 years MYRG always reported a positive cash flow from operatings.
MYRG Yearly Net Income VS EBIT VS OCF VS FCFMYRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

1.2 Ratios

MYRG's Return On Assets of 2.41% is in line compared to the rest of the industry. MYRG outperforms 55.56% of its industry peers.
MYRG's Return On Equity of 6.52% is in line compared to the rest of the industry. MYRG outperforms 55.56% of its industry peers.
MYRG's Return On Invested Capital of 4.87% is in line compared to the rest of the industry. MYRG outperforms 48.89% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MYRG is in line with the industry average of 11.58%.
The 3 year average ROIC (11.89%) for MYRG is well above the current ROIC(4.87%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.41%
ROE 6.52%
ROIC 4.87%
ROA(3y)6.44%
ROA(5y)5.79%
ROE(3y)15.08%
ROE(5y)13.85%
ROIC(3y)11.89%
ROIC(5y)10.63%
MYRG Yearly ROA, ROE, ROICMYRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 1.08%, MYRG is in line with its industry, outperforming 48.89% of the companies in the same industry.
In the last couple of years the Profit Margin of MYRG has grown nicely.
MYRG has a worse Operating Margin (1.57%) than 60.00% of its industry peers.
In the last couple of years the Operating Margin of MYRG has grown nicely.
The Gross Margin of MYRG (8.54%) is worse than 73.33% of its industry peers.
In the last couple of years the Gross Margin of MYRG has declined.
Industry RankSector Rank
OM 1.57%
PM (TTM) 1.08%
GM 8.54%
OM growth 3Y-2.73%
OM growth 5Y2.45%
PM growth 3Y-1.54%
PM growth 5Y4.22%
GM growth 3Y-6.61%
GM growth 5Y-1.73%
MYRG Yearly Profit, Operating, Gross MarginsMYRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

5

2. Health

2.1 Basic Checks

MYRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
MYRG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MYRG has been increased compared to 5 years ago.
MYRG has a better debt/assets ratio than last year.
MYRG Yearly Shares OutstandingMYRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
MYRG Yearly Total Debt VS Total AssetsMYRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

MYRG has an Altman-Z score of 4.28. This indicates that MYRG is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.28, MYRG is in the better half of the industry, outperforming 68.89% of the companies in the same industry.
MYRG has a debt to FCF ratio of 4.02. This is a neutral value as MYRG would need 4.02 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.02, MYRG is doing good in the industry, outperforming 62.22% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that MYRG is not too dependend on debt financing.
MYRG has a better Debt to Equity ratio (0.15) than 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 4.02
Altman-Z 4.28
ROIC/WACC0.41
WACC11.88%
MYRG Yearly LT Debt VS Equity VS FCFMYRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

MYRG has a Current Ratio of 1.35. This is a normal value and indicates that MYRG is financially healthy and should not expect problems in meeting its short term obligations.
MYRG has a Current ratio (1.35) which is in line with its industry peers.
A Quick Ratio of 1.35 indicates that MYRG should not have too much problems paying its short term obligations.
MYRG has a Quick ratio (1.35) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
MYRG Yearly Current Assets VS Current LiabilitesMYRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for MYRG have decreased strongly by -57.98% in the last year.
Measured over the past years, MYRG shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.72% on average per year.
MYRG shows a small growth in Revenue. In the last year, the Revenue has grown by 0.94%.
MYRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.93% yearly.
EPS 1Y (TTM)-57.98%
EPS 3Y15.92%
EPS 5Y23.72%
EPS Q2Q%-49.22%
Revenue 1Y (TTM)0.94%
Revenue growth 3Y17.48%
Revenue growth 5Y18.93%
Sales Q2Q%-5.47%

3.2 Future

Based on estimates for the next years, MYRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.97% on average per year.
The Revenue is expected to grow by 2.02% on average over the next years.
EPS Next Y-70.74%
EPS Next 2Y7.52%
EPS Next 3Y11.97%
EPS Next 5YN/A
Revenue Next Year-3.54%
Revenue Next 2Y-0.36%
Revenue Next 3Y2.02%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MYRG Yearly Revenue VS EstimatesMYRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
MYRG Yearly EPS VS EstimatesMYRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 61.61, the valuation of MYRG can be described as expensive.
MYRG's Price/Earnings ratio is a bit more expensive when compared to the industry. MYRG is more expensive than 62.22% of the companies in the same industry.
When comparing the Price/Earnings ratio of MYRG to the average of the S&P500 Index (28.47), we can say MYRG is valued expensively.
Based on the Price/Forward Earnings ratio of 22.52, the valuation of MYRG can be described as rather expensive.
MYRG's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, MYRG is valued rather cheaply.
Industry RankSector Rank
PE 61.61
Fwd PE 22.52
MYRG Price Earnings VS Forward Price EarningsMYRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MYRG.
68.89% of the companies in the same industry are cheaper than MYRG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 94.6
EV/EBITDA 19.77
MYRG Per share dataMYRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.6
EPS Next 2Y7.52%
EPS Next 3Y11.97%

0

5. Dividend

5.1 Amount

No dividends for MYRG!.
Industry RankSector Rank
Dividend Yield N/A

MYR GROUP INC/DELAWARE

NASDAQ:MYRG (2/4/2025, 8:00:01 PM)

After market: 141.09 0 (0%)

141.09

-0.35 (-0.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)N/A N/A
Inst Owners102.54%
Inst Owner Change-1.9%
Ins Owners1.75%
Ins Owner Change0.49%
Market Cap2.27B
Analysts81.82
Price Target191.42 (35.67%)
Short Float %4.54%
Short Ratio3.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-47.44%
Min EPS beat(2)-179.05%
Max EPS beat(2)84.18%
EPS beat(4)1
Avg EPS beat(4)-26.66%
Min EPS beat(4)-179.05%
Max EPS beat(4)84.18%
EPS beat(8)4
Avg EPS beat(8)-4.9%
EPS beat(12)6
Avg EPS beat(12)-2.95%
EPS beat(16)10
Avg EPS beat(16)7.2%
Revenue beat(2)0
Avg Revenue beat(2)-6.16%
Min Revenue beat(2)-7.24%
Max Revenue beat(2)-5.07%
Revenue beat(4)1
Avg Revenue beat(4)-2.47%
Min Revenue beat(4)-7.24%
Max Revenue beat(4)8.81%
Revenue beat(8)5
Avg Revenue beat(8)3.89%
Revenue beat(12)9
Avg Revenue beat(12)3.75%
Revenue beat(16)12
Avg Revenue beat(16)3.84%
PT rev (1m)0%
PT rev (3m)45.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-62.94%
EPS NY rev (1m)0%
EPS NY rev (3m)6.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.83%
Valuation
Industry RankSector Rank
PE 61.61
Fwd PE 22.52
P/S 0.64
P/FCF 94.6
P/OCF 20.94
P/B 3.86
P/tB 5.78
EV/EBITDA 19.77
EPS(TTM)2.29
EY1.62%
EPS(NY)6.27
Fwd EY4.44%
FCF(TTM)1.49
FCFY1.06%
OCF(TTM)6.74
OCFY4.78%
SpS219.4
BVpS36.51
TBVpS24.41
PEG (NY)N/A
PEG (5Y)2.6
Profitability
Industry RankSector Rank
ROA 2.41%
ROE 6.52%
ROCE 6.68%
ROIC 4.87%
ROICexc 4.91%
ROICexgc 6.44%
OM 1.57%
PM (TTM) 1.08%
GM 8.54%
FCFM 0.68%
ROA(3y)6.44%
ROA(5y)5.79%
ROE(3y)15.08%
ROE(5y)13.85%
ROIC(3y)11.89%
ROIC(5y)10.63%
ROICexc(3y)12.97%
ROICexc(5y)11.39%
ROICexgc(3y)17.33%
ROICexgc(5y)15%
ROCE(3y)16.31%
ROCE(5y)14.58%
ROICexcg growth 3Y0.49%
ROICexcg growth 5Y10.25%
ROICexc growth 3Y-0.67%
ROICexc growth 5Y8.78%
OM growth 3Y-2.73%
OM growth 5Y2.45%
PM growth 3Y-1.54%
PM growth 5Y4.22%
GM growth 3Y-6.61%
GM growth 5Y-1.73%
F-Score4
Asset Turnover2.22
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 4.02
Debt/EBITDA 0.76
Cap/Depr 131.33%
Cap/Sales 2.39%
Interest Coverage 250
Cash Conversion 90.62%
Profit Quality 62.68%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 4.28
F-Score4
WACC11.88%
ROIC/WACC0.41
Cap/Depr(3y)129.69%
Cap/Depr(5y)122.89%
Cap/Sales(3y)2.33%
Cap/Sales(5y)2.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.98%
EPS 3Y15.92%
EPS 5Y23.72%
EPS Q2Q%-49.22%
EPS Next Y-70.74%
EPS Next 2Y7.52%
EPS Next 3Y11.97%
EPS Next 5YN/A
Revenue 1Y (TTM)0.94%
Revenue growth 3Y17.48%
Revenue growth 5Y18.93%
Sales Q2Q%-5.47%
Revenue Next Year-3.54%
Revenue Next 2Y-0.36%
Revenue Next 3Y2.02%
Revenue Next 5YN/A
EBIT growth 1Y-55.54%
EBIT growth 3Y14.27%
EBIT growth 5Y21.84%
EBIT Next Year-14.56%
EBIT Next 3Y24.01%
EBIT Next 5YN/A
FCF growth 1Y-30.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.72%
OCF growth 3Y-25.99%
OCF growth 5Y-3.49%